AI assistant
AMGEN INC — Director's Dealing 2018
Aug 3, 2018
29819_dirs_2018-08-02_aac78803-2da4-4d5b-a4c6-d3507fbfa046.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2018-07-26
Reporting Person: REESE DAVID M (EVP, Research and Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17732 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Nqso (Right to Buy) | $58.43 | 2020-04-26 | Common Stock (1480) | Direct | |
| Nqso (Right to Buy) | $54.69 | 2021-04-25 | Common Stock (2300) | Direct | |
| Nqso (Right to Buy) | $156.35 | 2026-05-03 | Common Stock (8711) | Direct | |
| Nqso (Right to Buy) | $162.60 | 2027-05-01 | Common Stock (8714) | Direct | |
| Nqso (Right to Buy) | $177.46 | 2028-04-27 | Common Stock (7807) | Direct |
Footnotes
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 313 RSUs which vest fully in one installment on 1/30/2019; 686 RSUs which vest in installments of 338 and 348 on 5/3/2019 and 5/3/2020, respectively; 4,920 RSUs which vest in installments of 1,623, 1,624 and 1,673 on 5/1/2019, 5/1/2020 and 5/1/2021, respectively; 984 RSUs which vest in installments of 324, 325 and 335 on 5/1/2019, 5/1/2020 and 5/1/2021, respectively; and 1,014 RSUs which vest in installments of 334, 335 and 345 on 4/27/2020, 4/27/2021 and 4/27/2022, respectively.
F2: These shares include 282 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3: These options were fully exercisable on 4/26/2014.
F4: These options were fully exercisable on 4/25/2015.
F5: 2,874 of these options have vested and the remainder are exercisable in two installments of 2,875 and 2,962 on 5/3/2019 and 5/3/2020, respectively.
F6: These stock options are exercisable in three annual installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
F7: These stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively.